tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND

Ligand Pharma (LGND) Revenue

Compare
808 Followers

Ligand Pharma Revenue

Ligand Pharma had a revenue of 45.33M in the quarter ending Mar 31, 2025, with 5.89%. This bring the company's revenue in the last twelve months to 181.49M, Decreased 8.59%. In the fiscal year ending Dec 31, 2024, Ligand Pharma had annual revenue of 167.13M with 27.28% growth.
Revenue (ttm)
181.49M
Revenue Growth
53.40%
P/S Ratio
13.28
Revenue/Employee
$2,457,838
Employees
68
Market Cap
$2.22B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
167.13M35.82M+27.28%
Dec 31, 2023
131.31M-64.93M-33.09%
Dec 31, 2022
196.25M-80.89M-29.19%
Dec 31, 2021
277.13M90.71M+48.66%
Dec 31, 2020
186.42M66.14M+54.98%
Dec 31, 2019
120.28M-131.17M-52.17%
Dec 31, 2018
251.45M110.35M+78.21%
Dec 31, 2017
141.10M32.13M+29.48%
Dec 31, 2016
108.97M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis